Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 623879, 11 pages
http://dx.doi.org/10.1155/2012/623879
Review Article

Protective Effect of Proanthocyanidin against Diabetic Oxidative Stress

1Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan
2Department of Food Science and Nutrition, Pusan National University, Busan 609-735, Republic of Korea

Received 28 April 2011; Revised 1 June 2011; Accepted 9 June 2011

Academic Editor: Jae Youl Cho

Copyright © 2012 Takako Yokozawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Bonnefont-Rousselot, J. L. Beaudeux, P. Thérond, J. Peynet, A. Legrand, and J. Delattre, “Diabetes mellitus, oxidative stress and advanced glycation endproducts,” Annales Pharmaceutiques Francaises, vol. 62, no. 3, pp. 147–157, 2004. View at Google Scholar · View at Scopus
  2. D. Giugliano, A. Ceriello, and G. Paolisso, “Oxidative stress and diabetic vascular complications,” Diabetes Care, vol. 19, no. 3, pp. 257–267, 1996. View at Google Scholar · View at Scopus
  3. J. W. Baynes and S. R. Thorpe, “Role of oxidative stress in diabetic complications: a new perspective on an old paradigm,” Diabetes, vol. 48, no. 1, pp. 1–9, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Anderson, T. W. Yu, J. Wright, and C. Ioannides, “An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients,” Mutation Research, vol. 398, no. 1-2, pp. 151–161, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. B. K. Kilhovd, T. J. Berg, K. I. Birkeland, P. Thorsby, and K. F. Hanssen, “Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease,” Diabetes Care, vol. 22, no. 9, pp. 1543–1548, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. N. H. Ugochukwu, N. D. Bagayoko, and M. E. Antwi, “The effects of dietary caloric restriction on antioxidant status and lipid peroxidation in mild and severe streptozotocin-induced diabetic rats,” Clinica Chimica Acta, vol. 348, no. 1-2, pp. 121–129, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. V. Poitout and R. P. Robertson, “Minireview: secondary β-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity,” Endocrinology, vol. 143, no. 2, pp. 339–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Prentki, E. Joly, W. El-Assaad, and R. Roduit, “Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes,” Diabetes, vol. 51, no. 3, pp. S405–S413, 2002. View at Google Scholar · View at Scopus
  9. U. V. Mallavadhani, A. K. Panda, and Y. R. Rao, “Pharmacology and chemotaxonomy of diospyros,” Phytochemistry, vol. 49, no. 4, pp. 901–951, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Gorinstein, M. Zemser, M. Weisz et al., “Fluorometric analysis of phenolics in persimmons,” Bioscience, Biotechnology and Biochemistry, vol. 58, no. 6, pp. 1087–1092, 1994. View at Google Scholar
  11. S. Gorinstein, Z. Zachwieja, M. Folta et al., “Comparative contents of dietary fiber, total phenolics, and minerals in persimmons and apples,” Journal of Agricultural and Food Chemistry, vol. 49, no. 2, pp. 952–957, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Dixon, D. Y. Xie, and S. B. Sharma, “Proanthocyanidins—a final frontier in flavonoid research?” New Phytologist, vol. 165, no. 1, pp. 9–28, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. D. Y. Xie and R. A. Dixon, “Proanthocyanidin biosynthesis—still more questions than answers?” Phytochemistry, vol. 66, no. 18, pp. 2127–2144, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. Y. A. Lee, Y. J. Kim, E. J. Cho, and T. Yokozawa, “Ameliorative effects of proanthocyanidin on oxidative stress and inflammation in streptozotocin-induced diabetic rats,” Journal of Agricultural and Food Chemistry, vol. 55, no. 23, pp. 9395–9400, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. T. Tanaka, R. Takahashi, I. Kouno, and G. I. Nonaka, “Chemical evidence for the de-astringency (insolubilization of tannins) of persimmon fruit,” Journal of the Chemical Society, Perkin Transactions, no. 20, pp. 3013–3022, 1994. View at Google Scholar · View at Scopus
  16. S. de Pascual-Teresa, C. Santos-Buelga, and J. C. Rivas-Gonzalo, “Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages,” Journal of Agricultural and Food Chemistry, vol. 48, no. 11, pp. 5331–5337, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Santos-Buelga and A. Scalbert, “Proanthocyanidins and tannin-like compounds—nature, occurrence, dietary intake and effects on nutrition and health,” Journal of the Science of Food and Agriculture, vol. 80, no. 7, pp. 1094–1117, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. A. Lee, E. J. Cho, and T. Yokozawa, “Effects of proanthocyanidin preparations on hyperlipidemia and other biomarkers in mouse model of type 2 diabetes,” Journal of Agricultural and Food Chemistry, vol. 56, no. 17, pp. 7781–7789, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. K. Shimoi, A. Okitsu, M. H. L. Green et al., “Oxidative DNA damage induced by high glucose and its suppression in human umbilical vein endothelial cells,” Mutation Research, vol. 480-481, pp. 371–378, 2001. View at Google Scholar · View at Scopus
  20. J. L. Figarola, S. Scott, S. Loera, B. Xi, T. Synold, and S. Rahbar, “Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats,” Annals of the New York Academy of Sciences, vol. 1043, pp. 767–776, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. Y. J. Kim, T. Yokozawa, and H. Y. Chung, “Effects of energy restriction and fish oil supplementation on renal guanidino levels and antioxidant defences in aged lupus-prone B/W mice,” British Journal of Nutrition, vol. 93, no. 6, pp. 835–844, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. J. Kim, T. Yokozawa, and H. Y. Chung, “Suppression of oxidative stress in aging NZB/NZW mice: effect of fish oil feeding on hepatic antioxidant status and guanidino compounds,” Free Radical Research, vol. 39, no. 10, pp. 1101–1110, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. H. Y. Chung, H. J. Kim, J. W. Kim, and B. P. Yu, “The inflammation hypothesis of aging: molecular modulation by calorie restriction,” Annals of the New York Academy of Sciences, vol. 928, pp. 327–335, 2001. View at Google Scholar · View at Scopus
  24. Y. Lin, A. H. Berg, P. Iyengar et al., “The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species,” Journal of Biological Chemistry, vol. 280, no. 6, pp. 4617–4626, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. S. M. Chung, E. C. M. Ho, K. S. L. Lam, and S. K. Chung, “Contribution of polyol pathway to diabetes-induced oxidative stress,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. S233–S236, 2003. View at Google Scholar · View at Scopus
  26. N. H. Ugochukwu and M. K. Cobourne, “Modification of renal oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with extracts from Gongronema latifolium leaves,” Clinica Chimica Acta, vol. 336, no. 1-2, pp. 73–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. J. Surh, K. S. Chun, H. H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation,” Mutation Research, vol. 480-481, pp. 243–268, 2001. View at Google Scholar · View at Scopus
  28. R. M. Touyz and E. L. Schiffrin, “Reactive oxygen species in vascular biology: implications in hypertension,” Histochemistry and Cell Biology, vol. 122, no. 4, pp. 339–352, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. L. Feng, Y. Xia, G. E. Garcia, D. Hwang, and C. B. Wilson, “Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide,” Journal of Clinical Investigation, vol. 95, no. 4, pp. 1669–1675, 1995. View at Google Scholar · View at Scopus
  30. W. L. Smith, E. A. Meade, and D. L. DeWitt, “Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2,” Annals of the New York Academy of Sciences, vol. 714, pp. 136–142, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Goppelt-Struebe, “Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 52, no. 4, pp. 213–222, 1995. View at Google Scholar · View at Scopus
  32. E. J. Noh, K. S. Ahn, E. M. Shin, S. H. Jung, and Y. S. Kim, “Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-κB activation in RAW 264.7 macrophages,” Life Sciences, vol. 79, no. 7, pp. 695–701, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. Q. Li and I. M. Verma, “NF-κB regulation in the immune system,” Nature Reviews Immunology, vol. 2, no. 10, pp. 725–734, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. T. Horigome, R. Kumar, and K. Okamoto, “Effects of condensed tannins prepared from leaves of fodder plants on digestive enzymes in vitro and in the intestine of rats,” British Journal of Nutrition, vol. 60, no. 2, pp. 275–285, 1988. View at Google Scholar · View at Scopus
  35. Y. Shishikura, S. Khokhar, and B. S. Murray, “Effects of tea polyphenols on emulsification of olive oil in a small intestine model system,” Journal of Agricultural and Food Chemistry, vol. 54, no. 5, pp. 1906–1913, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Are oxidative stress—activated signaling pathways mediators of insulin resistance and β-cell dysfunction?” Diabetes, vol. 52, no. 1, pp. 1–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Niki, Y. Yamamoto, E. Komuro, and K. Sato, “Membrane damage due to lipid oxidation,” American Journal of Clinical Nutrition, vol. 53, no. 1, pp. 201S–205S, 1991. View at Google Scholar · View at Scopus
  38. M. C. Bravi, A. Armiento, O. Laurenti et al., “Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus,” Metabolism, vol. 55, no. 5, pp. 691–695, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. C. H. Wu and G. C. Yen, “Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts,” Journal of Agricultural and Food Chemistry, vol. 53, no. 8, pp. 3167–3173, 2005. View at Google Scholar · View at Scopus
  40. N. Yahagi, H. Shimano, A. H. Hasty et al., “Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice,” Journal of Biological Chemistry, vol. 277, no. 22, pp. 19353–19357, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. H. Shimano, N. Yahagi, M. Amemiya-Kudo et al., “Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes,” Journal of Biological Chemistry, vol. 274, no. 50, pp. 35832–35839, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Tobe, R. Suzuki, M. Aoyama et al., “Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2-/- mouse liver,” Journal of Biological Chemistry, vol. 276, no. 42, pp. 38337–38340, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. Z. Wang, T. Jiang, J. Li et al., “Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes,” Diabetes, vol. 54, no. 8, pp. 2328–2335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Ferré, “The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity,” Diabetes, vol. 53, no. 1, pp. S43–S50, 2004. View at Google Scholar · View at Scopus
  45. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes,” Endocrine Reviews, vol. 23, no. 5, pp. 599–622, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Celec, “Nuclear factor kappa B—molecular biomedicine: the next generation,” Biomedicine and Pharmacotherapy, vol. 58, no. 6-7, pp. 365–371, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. S. Sinha, G. Perdomo, N. F. Brown, and R. M. O'Doherty, “Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor κB,” Journal of Biological Chemistry, vol. 279, no. 40, pp. 41294–41301, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. M. Fujimoto, N. Shimizu, K. Kunii, J. A. J. Martyn, K. Ueki, and M. Kaneki, “A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice,” Diabetes, vol. 54, no. 5, pp. 1340–1348, 2005. View at Publisher · View at Google Scholar · View at Scopus